Factors impacting treatment with a CDK4/6i in first line metastatic HR+/HER2- breast cancer patients. Estimation of the effect of the characteristics under study on the likelihood of a high initial CA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results